SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2475)10/25/1997 7:22:00 PM
From: Steve Fancy   of 6136
 
>>...It all sounds great--if you bought the stock a year ago. It's up
126% since then. But today, with a fiscal 1998 P/E hovering around 75...<<

I don't know how Fortune magazine figures their P/E, must have
been before the earnings revisions. In checking Zacks and First
Call, I found the following mean estimates, P/E's calculated with
stock price of 50:

Zacks First Call

98 EPS/PE .87/57.47 .89/56.17

99 EPS/PE 1.86/26.88 1.75/28.57

Next 5 year growth rate 67.5 N/A

For the heck of it, PaineWebber's revised estimates as of 10/15:

98 EPS/PE 1.00/50.00

99 EPS/PE 2.31/21.64

sf



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News